Toward Gene Therapy for Human CD3 Deficiencies

Human Gene Therapy

Volumn 14, Issue 17, 2003, Pages 1653-1661

  Pacheco Castro, A ^a,b   Martin Fernandez J M ^a   Millan R ^a   Sanal, O ^c   Allende, L ^d   Regueiro, J R ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSIDAD ALFONSO X EL SABIO   (Spain)

^c HACETTEPE UNIVERSITY   (Turkey)

^d HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; PROTEIN SUBUNIT; T LYMPHOCYTE RECEPTOR;

ANTIGEN EXPRESSION; ARTICLE; BLOOD CELL; CASE REPORT; DOWN REGULATION; GENE DELIVERY SYSTEM; GENE THERAPY; GENE TRANSFER; HUMAN; PROTEIN DEFICIENCY; RETROVIRUS; SIDE EFFECT; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANTIGENS, CD3; ANTIGENS, CD4; ANTIGENS, CD8; CALIBRATION; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; INTERLEUKIN-2; LEUKOCYTE DISORDERS; LUMINESCENT PROTEINS; MUTATION; PHENOTYPE; RECEPTORS, ANTIGEN, T-CELL; RETROVIRIDAE; T-LYMPHOCYTES; TIME FACTORS;

UNIDENTIFIED RETROVIRUS;

EID: 0344874128     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303403322542293     Document Type: Article

References (36)

1. ALARCÓN, B., LEY, S.C., SANCHEZ-MADRID, F., BLUMBERG, R.S., JU, S.T., FRESNO, M., and TERHORST, C. (1991). The CD3-γ and CD3-δ subunits of the T cell antigen receptor can be expressed within distinct functional TCR/CD3 complexes. EMBO J. 10, 903-912.
2. ARNAIZ-VILLENA, A., TIMON, M., CORELL, A., PEREZ-ACIEGO, P., MARTIN-VILLA, J.M., and REGUEIRO, J.R. (1992). Brief report: Primary immunodeficiency caused by mutations in the gene encoding the CD3-γ subunit of the T-lymphocyte receptor. N. Engl. J. Med. 327, 529-533.
3. ASSENMACHER, M., SCHMITZ, J., and RADBRUCH, A. (1994). Flow cytometric determination of cytokines in activated murine T helper lymphocytes: Expression of interleukin-10 in interferon-γ and in interleukin-4-expressing cells. Eur. J. Immunol. 24, 1097-1101.
4. BARRY, S.C., SEPPEN, J., RAMESH, N., FOSTER, J.L., SEYAMA, K., OCHS, H.D., GARCIA, I.V., and OSBORNE, W.R. (2000). Lentiviral and murine retroviral transduction of T cells for expression of human CD40 ligand. Hum. Gene Ther. 11, 323-332.
5. BLAESE, R.M., CULVER, K.W., MILLER, A.D., CARTER, C.S., FLEISHER, T., CLERICI, M., SHEARER, G., CHANG, L., CHIANG, Y., and TOLSTOSHEV, P. (1995). T lymphocyte-directed gene therapy for ADA-SCID: Initial trial results after 4 years. Science 270, 475-480.
6. BUCKLEY, R.H. (2000). Primary immunodeficiency diseases due to defects in lymphocytes. N. Engl. J. Med. 343, 1313-1324.
7. CARBONE, E., TERRAZZANO, G., MELIAN, A., ZANZI, D., MORETTA, L., PORCELLI, S., KARRE, K., and ZAPPACOSTA, S. (2000). Inhibition of human NK cell-mediated killing by CD1 molecules. J. Immunol. 164, 6130-6137.
8. CAVAZZANA-CALVO, M., HACEIN-BEY, S., DE SAINT, B.G., GROSS, F., YVON, E., NUSBAUM, P., SELZ, F., HUE, C., CERTAIN, S., CASANOVA, I.L., BOUSSO, P., DEIST, F.L., and FISCHER, A. (2000). Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288, 669-672.
9. CLAY, T.M., CUSTER, M.C., SACHS, I., HWU, P., ROSENBERG, S.A., and NISHIMURA, M.T. (1999). Efficient transfer of a tumor antigen-reactive TCR to human peripheral blood lymphocytes confers anti-tumor reactivity. J. Immunol. 163, 507-513.
10. DARDALHON, V., NORAZ, N., POLLOK, K., REBOUISSOU, C., BOYER, M., BAKKER, A.Q., SPITS, H., and TAYLOR, N. (1999). Green fluorescent protein as a selectable marker of fibronectin-facilitated retroviral gene transfer in primary human T lymphocytes. Hum. Gene Ther. 10, 5-14.
11. DE LA CALLE-MARTIN, O., HERNANDEZ, M., ORDI, J., CASAMITJANA, N., AROSTEGUI, J.I., CARAGOL, I., FERRANDO, M., LABRADOR, M., RODRIGUEZ-SANCHEZ, J.L., and ESPANOL, T. (2001). Familial CD8 deficiency due to a mutation in the CD8 gene. J. Clin. Invest. 108, 117-123.
12. DELGADO, P., FERNANDEZ, E., DAVE, V., KAPPES, D., and ALARCON, B. (2000). CD3δ couples T-cell receptor signalling to ERK activation and thymocyte positive selection. Nature 406, 426-430.
13. DIETRICH, J., HOU, X., WEGENER, A.M., and GEISLER, C. (1994). CD3 γ contains a phosphoserine-dependent di-leucine motif involved in down-regulation of the T cell receptor. EMBO J. 13, 2156-2166.
14. FISCHER, A., HACEIN-BEY, S., LE DEIST, F., DE SAINT BASILE, G., and CAVAZZANA-CALVO, M. (2001). Gene therapy for human severe combined immunodeficiencies. Immunity 15, 1-4.
15. 2-microglobulin-deficient mice is biased towards reactivity against self-major histocompatibility class I. J. Exp. Med. 179, 661-672.
16. JENSEN, M.C., CLARKE, P., TAN, G., WRIGHT, C., CHUNG-CHANG, W., CLARK, T.N., ZHANG, F., SLOVAK, M.L., WU, A.M., FORMAN, S.J., and RAUBITSCHEK, A. (2000). Human T lymphocyte genetic modification with naked DNA. Mol. Ther. 1, 49-55.
17. LAM, J.S., REEVES, M.E., COWHERD, R., ROSENBERG, S.A., and HWU, P. (1996). Improved gene transfer into human lymphocytes using retroviruses with the gibbon ape leukemia virus envelope. Hum. Gene Ther. 7, 1415-1422.
18. -,- mice overtly react with self-major histocompatibility complex molecules upon restoration of normal surface density of T cell receptor-CD3 complex. J. Exp. Med. 185, 707-715.
19. LIU, C.C., JIANG, S., PERSECHINI, P.M., ZYCHLINSKY, A., KAUFMANN, Y., and YOUNG, J.D. (1989). Resistance of cytolytic lymphocytes to perforin-mediated killing: Induction of resistance correlates with increase in cytotoxicity. J. Exp. Med. 169, 2211-2225.
20. MALISSEN, B., ARDOUIN, L., LIN, S.Y., GILLET, A., and MALISSEN, M. (1999). Function of the CD3 subunits of the pre-TCR and TCR complexes during T cell development. Adv. Immunol. 72, 103-148.
21. + T cells in human immunodeficiency virus-infected subjects. Blood 96, 785-793.
22. MOVASSAGH, M., BOYER, O., BURLAND, M.C., LECLERCQ, V., KLATZMANN, D., and LEMOINE, F.M. (2000). Retrovirus-mediated gene transfer into T cells: 95% transduction efficiency without further in vitro selection. Hum. Gene Ther. 11, 1189-1200.
23. NAKAMURA, H., ZARYCKI, J., SULLIVAN, J.L., and JUNG, J.U. (2001 ). Abnormal T cell receptor signal transduction of CD4 Th cells in X-linked lymphoproliferative syndrome. J. Immunol. 167, 2657-2665.
24. + T lymphocytes. J. Immunol. 161, 3152-3160.
25. RAMIRO, A.R., DE YEBENES, V.G., TRIGUEROS, C., CARRASCO, Y.R., and TORIBIO, M.L. (1998). Enhanced green fluorescent protein as an efficient reporter gene for retroviral transduction of human multipotent lymphoid precursors. Hum. Gene Ther. 9, 1103-1109.
26. SIEG, S.F., BAZDAR, D.A., HARDING, C.V., and LEDERMAN, M.M. (2001). Differential expression of interleukin-2 and γ interferon in human immunodeficiency virus disease. J. Virol. 75, 9983-9985.
27. SOUDAIS, C., DE VILLARTAY, J.P., LE DEIST, F., FISCHER, A., and LISOWSKA-GROSPIERRE, B. (1993). Independent mutations of the human CD3-ε gene resulting in a T cell receptor/CD3 complex immunodeficiency. Nat. Genet. 3, 77-81.
28. STANISLAWSKI, T., VOSS, R.H., LOTZ, C., SADOVNIKOVA, E., WILLEMSEN, R.A., KUBALL, J., RUPPERT, T., BOLHUIS, R.L., MELIEF, C.J., HUBER, C., STAUSS, H.J., and THEOBALD, M. (2001). Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer. Nat. Immunol. 2, 962-970.
29. STEINBERG, M., SWAINSON, L., SCHWARZ, K., BOYER, M., FRIEDRICH, W., YSSEL, H., TAYLOR, N., and NORAZ, N. (2000). Retrovirus-mediated transduction of primary ZAP-70-deficient human T cells results in the selective growth advantage of gene-corrected cells: Implications for gene therapy. Gene Ther. 7, 1392-1400.
30. SUN, J.Y., PACHECO-CASTRO, A., BORROTO, A., ALARCON, B., ALVAREZ-ZAPATA, D., and REGUEIRO, J.R. (1997). Construction of retroviral vectors carrying human CD3 γ cDNA and reconstitution of CD3 γ expression and T cell receptor surface expression and function in a CD3 γ-deficient mutant T cell line. Hum. Gene Ther. 8, 1041-1048.
31. TORRES, P.S., ALCOVER, A., ZAPATA, D.A., ARNAUD, J., PACHECO, A., MARTIN-FERNANDEZ, J.M., VILLASEVIL, E.M., SANAL, O., and REGUEIRO, J.R. (2003). TCR dynamics in human mature T lymphocytes lacking CD3γ. J. Immunol. 170, 5947-5955.
32. VAN TOL, M.J.D., SANAL, O., LANGLOIS VAN DER BERGH, R., VAN DEL WAL, Y., ROSENBERG, S.A., BERKEL, A.I., VOSSEN, J.M., and KONING, F. (1997). CD3-γ chain deficiency leading to a cellular immunodeficiency with mild clinical presentation. Immunologist 1, 41.
33. WADA, T., JAGADEESH, G.J, NELSON, D.L., and CANDOTTI, F. (2002). Retrovirus-mediated WASP gene transfer corrects Wiskott-Aldrich syndrome T-cell dysfunction. Hum. Gene Ther. 13, 1039-1046.
34. WANG, X., and MOSMANN, T. (2001). In vivo priming of CD4 T cells that produce interleukin (IL)-2 but not IL-4 or interferon (IFN)-γ, and can subsequently differentiate into IL-4-or IFN-γ-secreting cells. J. Exp. Med. 194, 1069-1080.
35. WEISS, A., and LITTMAN, D.R. (1994). Signal transduction by lymphocyte antigen receptors. Cell 76, 263-274.
36. ZAPATA, D.A., PACHECO-CASTRO, A., TORRES, P.S., MILLAN, R., and REGUEIRO, J.R. (2000). CD3 immunodeficiencies. Immunol. Allergy Clin. North Am. 20, 1-17.